HALO logo
halo search icon
Erasca, Inc.

US$11.12

Price Change Indicator
0.80 (7.75%)
Erasca, Inc.
ERAS · NAS

Erasca, Inc.

Start Trading ERAS for Free

US$11.12

Price Arrow0.80 (7.75%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownHALO AllHALO Consensus ValueRecent Earnings downgradeRecent Price upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Erasca, Inc. Overview

ERAS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

About ERAS

icon

Website

Erasca, Inc.

icon

Telephone

1.858.465.6511

icon

Address

Suite 300, 3115 Merryfield Row, San Diego, CA 92121

Description

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

ERAS Price Chart

Key Stats

Market Cap

US$3.21B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.06 - 24.28

Trade Value (12mth)

US$8,720,155.00

1 week

0.88%

1 month

-53.95%

YTD

187.47%

1 year

745.9%

All time high

24.47

Key Fundamentals

EPS 3 yr Growth

-77.90%

EBITDA Margin

0.00%

Operating Cashflow

-$95m

Free Cash Flow Return

-22.80%

ROIC

-29.70%

Interest Coverage

0.00

Quick Ratio

10.00

Other Data

Shares Outstanding (Fully Diluted)

304m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ERAS Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
12 May 26
12 May 26
28 April 26

ERAS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.83-0.69-0.44locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.83-0.69-0.44locklocklock
Growth
 %locklocklocklock58.21736.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Erasca, Inc. (ERAS:NAS)?
Halo FAQ
The current share price of Erasca, Inc. (ERAS:NAS) is USD$11.12.
What is the 52-week high share price for Erasca, Inc. (ERAS:NAS)?
Halo FAQ
The 52-week high share price for Erasca, Inc. (ERAS:NAS) is USD$24.28.
What is the 52-week low share price for Erasca, Inc. (ERAS:NAS)?
Halo FAQ
The 52-week low share price for Erasca, Inc. (ERAS:NAS) is USD$1.06.
What is the dividend yield for Erasca, Inc. (ERAS:NAS)?
Halo FAQ
Erasca, Inc. (ERAS:NAS) does not pay a dividend.
What was Erasca, Inc. (ERAS:NAS) last dividend payment?
Halo FAQ
Erasca, Inc. (ERAS:NAS) does not pay a dividend.
What is the franking level for Erasca, Inc. (ERAS:NAS)?
Halo FAQ
Erasca, Inc. (ERAS:NAS) has a franking level of 0.00%.
In which sector is Erasca, Inc. (ERAS:NAS) classified?
Halo FAQ
Erasca, Inc. (ERAS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial